drugset / Trial / NCT02782897
Intravenous Immunoglobulin for Acute Intracranial Hemorrhage
Non-randomizedParallel-groupSingle-blindTreatment
Summary
This pilot study aims to investigate whether intravenous immunoglobulin is safe and effective in alleviating perihematomal edema and neurologic deficits in patients with intracranial hemorrhage.
Timeline
- Start
- 2016-06
- Primary completion
- 2017-12
- Completion
- 2018-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Immune Globulin Intravenous (Human) | Protein / enzyme biologic | 0.4 g/kg | Intravenous |